INVOX
invoX Pharma Limited
Application Filed: 2022-05-26
Trademark Application Details
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79347617 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Timeline
| 2022-05-26 | Application Filed |
| 2022-08-18 | Location: INITIAL REVIEW/SERIALIZATION BRANCH(MAILROOM) |
| 2022-08-18 | Status: Live/Pending |
| 2022-08-19 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  invoX Pharma Limited |
| Entity Statement | Limited Company |
| Address | 1 Princeton Mews, GB |
| Legal Entity Type | |
| Legal Entity State | GB |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 005,006,018,044,046,051,052 |
| International Codes: | 10 |
| U.S. Codes: | 026,039,044 |
| International Codes: | 36 |
| U.S. Codes: | 100,101,102 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| International Codes: | 45 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceuticals; pharmaceutical preparations for medical purposes excluding insecticides, disinfectants, sterilisers and swimming-pool additives for inhibiting algae; chemical preparations for pharmaceutical purposes; chemical reagents for medical use; biotechnological preparations for medical use; biological adjuvants for medical purposes; biochemical preparations for medical use; preparations for deodorizing air; deodorants for health/medical purposes; oils for medical purposes; air purifying preparations, pharmaceutical preparations for inhalers; none of the aforesaid goods being disinfectants or sanitary preparations, and not being adapted for use as disinfectant or sanitisers; none of the aforesaid being goods for use in the examination, processing, transportation or testing of veterinary or medical samples |
| GS0051 | Pharmaceuticals for use in oncology, cardio-respiratory, haematology and immunity, paediatric and regenerative medicine; Pharmaceutical preparations and substances for oncology, cardio-respiratory, haematology and immunity, paediatric and regenerative medicine and for the prevention and treatment of inflammation and infectious diseases; chemical preparations for pharmaceutical purposes, namely, for use in oncology, cardio-respiratory, haematology and immunity, paediatric and regenerative medicine and for the treatment of inflammation and infectious diseases; chemical reagents for medical use; biotechnological preparations for medical use for use in oncology, cardio-respiratory, haematology and immunity, paediatric and regenerative medicine and for the treatment of inflammation and infectious diseases; biological adjuvants for medical purposes; biochemical preparations for medical use for use in oncology, cardio-respiratory, haematology and immunity, paediatric and regenerative medicine and for the treatment of inflammation and infectious diseases; preparations for deodorizing air; medicated deodorants for health and medical purposes; oils for medical purposes; air purifying preparations, pharmaceutical preparations for inhalers; none of the aforesaid goods being disinfectants or sanitary preparations, and not being adapted for use as disinfectant or sanitisers; none of the aforesaid being goods for use in diagnostics or for use in the examination, processing, transportation or testing of veterinary or medical samples |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2022-08-18 | 1 REPR M: |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2022-08-19 | 2 NWOS I:Incoming Correspondence |
| APPLICATION FILING RECEIPT MAILED | 2022-08-23 | 3 MAFR O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2023-03-14 | 4 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2023-03-15 | 5 CNRT R:Renewal |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2023-03-16 | 6 RFCR E:E-Mail |
| REFUSAL PROCESSED BY MPU | 2023-05-04 | 7 RFRR P: |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2023-05-04 | 8 RFCS P: |
| REFUSAL PROCESSED BY IB | 2023-05-24 | 9 RFNT P: |
| LIMITATION OF GOODS RECEIVED FROM IB | 2023-07-30 | 10 LIMG M: |
| LIMITATION FROM THE IB - REQUEST EXAM REVIEW | 2023-10-24 | 11 LIME X:Correction |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2023-11-06 | 12 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2023-11-06 | 13 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2023-11-07 | 14 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2023-12-05 | 15 CNSA O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2023-12-20 | 16 NONP E:E-Mail |
| NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | 2023-12-20 | 17 OP2R P: |
| NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2023-12-20 | 18 OPNS P: |
| NOTIFICATION PROCESSED BY IB | 2024-01-08 | 19 GPNX P: |
| PUBLISHED FOR OPPOSITION | 2024-01-09 | 20 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2024-01-09 | 21 NPUB E:E-Mail |
| NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | 2024-01-24 | 22 OPNR P: |
| NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2024-01-24 | 23 OPNS P: |
| NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | 2024-02-13 | 24 OPNX P: |
| REGISTERED-PRINCIPAL REGISTER | 2024-03-26 | 25 R.PR A:Allowance for Publication |
| NOTICE OF REGISTRATION CONFIRMATION EMAILED | 2024-03-26 | 26 NRCC E:E-Mail |
| FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2024-06-27 | 27 FICR P: |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 